Nine Proptech Finalists Named for 2026 Edge Pitch Battle
Live competition at Edge: The Tech and Data Forum showcases proptech companies solving real problems across the entire real estate lifecycle — from getting found to closing to running the business
"The
The 2026 Edge Pitch Battle finalists, in alphabetical order:
- 10xSearch — helps real estate firms get found and cited across today's search and AI answer engines.
- Agent Buddi — a hands-free assistant for agents, including newly launched safety features such as background checks and distress detection.
- FIJIapp — brokerage valuation and confidential buyer matching for owners exploring a merger or sale.
- homhub — an open, peer-to-peer listing and operating system that reimagines the traditional MLS model.
- Open Houses Direct — a modern open-house platform connecting agents with prospective buyers.
- Pairgap — expands access to homeownership through co-buying and affordability tools.
- Purlin — an end-to-end platform that guides a transaction from search to close; the most scaled of this year's group.
- RealAnalytica — analytics and data that help brokerages make sharper business decisions.
- VIZO — matches consumers with the agent best suited to their needs.
Edge: The Tech and Data Forum takes place
About T3 Sixty
T3 Sixty is the leader in management consultancy and research in the residential real estate industry. Now in its 28th year of operation, the company is also the leading publisher of many annual reports, including the Swanepoel Trends Report, Swanepoel Power 200 and the Real Estate Almanac. For more information, visit www.t3sixty.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nine-proptech-finalists-named-for-2026-edge-pitch-battle-302889411.html
SOURCE T3 Sixty
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PAINSTUDY Inc. Targets 'Self-Medication' Demand with Functional Muscle and Joint Patches
- SEEKOUT Moves Beyond Japan into North America and Europe, Accelerating Global Push in Premium Pet Market
- HUTCHMED Initiates Global Trial of KRAS-EGFR-Antibody Conjugate Therapy HMPL-A830 in Patients with Solid Tumors
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share